FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

317092009: Magnesium trisilicate+belladonna 0.15mg tablet (product)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    461680019 Magnesium trisilicate+belladonna 0.15mg tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1187962018 Magnesium trisilicate+belladonna 0.15mg tablet (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    461680019 Magnesium trisilicate+belladonna 0.15mg tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    461680019 Magnesium trisilicate+belladonna 0.15mg tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    714051017 Magnesium trisilicate+belladonna 0.15mg tablet (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1187962018 Magnesium trisilicate+belladonna 0.15mg tablet (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1187962018 Magnesium trisilicate+belladonna 0.15mg tablet (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Magnesium trisilicate+belladonna 0.15mg tablet Is a Product containing belladonna false Inferred relationship Existential restriction modifier (core metadata concept)
    Magnesium trisilicate+belladonna 0.15mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Naturally occurring alkaloid (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Magnesium trisilicate+belladonna 0.15mg tablet Is a Product containing belladonna and magnesium trisilicate false Inferred relationship Existential restriction modifier (core metadata concept)
    Magnesium trisilicate+belladonna 0.15mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Magnesium-based antacid false Inferred relationship Existential restriction modifier (core metadata concept)
    Magnesium trisilicate+belladonna 0.15mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Trace element supplementation false Inferred relationship Existential restriction modifier (core metadata concept)
    Magnesium trisilicate+belladonna 0.15mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Magnesium false Inferred relationship Existential restriction modifier (core metadata concept)
    Magnesium trisilicate+belladonna 0.15mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Aluminium false Inferred relationship Existential restriction modifier (core metadata concept)
    Magnesium trisilicate+belladonna 0.15mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Magnesium trisilicate (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Magnesium trisilicate+belladonna 0.15mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Belladonna (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Magnesium trisilicate+belladonna 0.15mg tablet Has manufactured dose form A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. false Inferred relationship Existential restriction modifier (core metadata concept)
    Magnesium trisilicate+belladonna 0.15mg tablet Has manufactured dose form Conventional release oral tablet (dose form) false Inferred relationship Existential restriction modifier (core metadata concept)
    Magnesium trisilicate+belladonna 0.15mg tablet Is a Product containing belladonna in oral dosage form false Inferred relationship Existential restriction modifier (core metadata concept)
    Magnesium trisilicate+belladonna 0.15mg tablet Is a Product containing belladonna alkaloid and magnesium trisilicate (medicinal product) false Inferred relationship Existential restriction modifier (core metadata concept)
    Magnesium trisilicate+belladonna 0.15mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Belladonna alkaloids - chemical (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Magnesium trisilicate+belladonna 0.15mg tablet Is a Product containing belladonna alkaloid in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier (core metadata concept)
    Magnesium trisilicate+belladonna 0.15mg tablet Is a TEMPORARY parent for CDs that are not updated false Inferred relationship Existential restriction modifier (core metadata concept)

    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator attribute value reference set (foundation metadata concept)

    REPLACED BY association reference set (foundation metadata concept)

    Back to Start